Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

133

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
M05BA06	BONVIVA	B	Ibandronic acid - 3mg/3ml	3mg/3ml	Injectable solution	3,144,591 L.L
A04AA02	KYTRIL	B	Granisetron (HCl) - 3mg/3ml	3mg/3ml	Injectable solution	3,711,693 L.L
A04AA02	GRANI-DENK	G	Granisetron - 3mg/3ml	3mg/3ml	Injectable concentrate for solution	1,679,803 L.L
A04AA02	NEOSET	G	Granisetron (HCl) - 3mg/3ml	3mg/3ml	Injectable solution	405,840 L.L
S02AA15	CETRAXAL OTICO	G	Ciprofloxacine (HCl) - 3mg/ml	3mg/ml	Drops	821,088 L.L
S02AA16	OFLOMED	G	Ofloxacin - 3mg/ml	3mg/ml	Drops solution	317,403 L.L
S03AA07	API-CIPROCIN	G	Ciprofloxacine (HCl) - 3mg/ml	3mg/ml	Drops	530,818 L.L
S01AE01	FLOXIGEN	G	Ofloxacin - 3mg/ml	3mg/ml	Drops solution	358,806 L.L
S01AE01	OPTIFLOX	G	Ofloxacin - 3mg/ml	3mg/ml	Drops suspension	143,791 L.L
S01AE01	FLOXEDOL	G	Ofloxacin - 3mg/ml	3mg/ml	Gel	339,992 L.L
S01AE02	NAFLOX	G	Norfloxacin - 3mg/ml	3mg/ml	Drops	370,901 L.L
S01AE03	CILOXAN	B	Ciprofloxacine (HCl) - 3mg/ml	3mg/ml	Drops solution	348,055 L.L
S01AE06	TYMER	G	Gatifloxacin (sesquihydrate) - 3mg/ml	3mg/ml	Drops solution	427,342 L.L
C01CA26	EPHEDRINE AGUETTANT	G	Ephedrine HCl - 3mg/ml	3mg/ml	Injectable solution	7,827,491 L.L
J01FA02	ROVAMYCINE	B	Spiramycin - 3MIU	3MIU	Tablet, film coated	649,076 L.L
D10AF02	ERYFLUID	B	Erythromycin base - 40mg/ml	4%	Lotion	542,912 L.L
D10AF02	ERYFLUID	B	Erythromycin base - 4%	4%	Lotion	542,912 L.L
D10AF02	MED-ERYTHROMYCIN 4%	G	Erythromycin - 40mg/ml	4%	Solution	235,492 L.L
D10AF02	SPOTEX	G	Erythromycin - 4%	4%	Gel	854,684 L.L
D11AX11	AVOQUIN	G	Hydroquinone - 4%	4%	Cream	916,501 L.L
B05AA06	GELASPAN	B	Gelatine, succinylated - 4%	4%	Injectable solution	9,107,572 L.L
C01CA04	DOPAMINE RENAUDIN	G	Dopamine HCl - 200mg/5ml	4%	Injectable concentrated solution	1,107,326 L.L
B03XA01	EPOTEX 4000 BENTA	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 4,000IU	4,000IU	Injectable solution	1,209,458 L.L
B03XA01	EPOTEX 4000 BENTA	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 4,000IU	4,000IU	Injectable solution	5,488,046 L.L
B03XA01	HEMAX	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 4,000IU	4,000IU	Injectable freeze dried substance+diluent	940,690 L.L
B03XA01	HEMAX	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 4,000IU	4,000IU	Injectable freeze dried substance+diluent	33,852,747 L.L
B03XA01	BINOCRIT	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 4,000IU/0.4ml	4,000IU/0.4ml	Injectable solution	5,582,795 L.L
B03XA01	EPOTIN	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 4,000IU/ml	4,000IU/ml	Injectable solution	11,317,795 L.L
B01AB05	ENOXA MEDIS	BioTech	Enoxaparin sodium - 4,000U Anti-Xa/0.4ml	4,000U Anti-Xa/0.4ml	Injectable solution	755,239 L.L
B01AB05	LOVENOX	BioTech	Enoxaparin sodium - 4,000UI (40mg)/0.4ml	4,000UI (40mg)/0.4ml	Injectable solution	886,936 L.L

...

133

...